Literature DB >> 26705747

Analysis of molecular epidemiologic characteristics of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli colonizing feces in hospital patients and community dwellers in a Japanese city.

Akihiro Nakamura1, Masaru Komatsu2, Nobuyoshi Noguchi3, Yuki Ohno3, Eriko Hashimoto3, Hiroko Matsutani3, Noriyuki Abe3, Saori Fukuda3, Hisashi Kohno3, Fumihiko Nakamura3, Shuji Matsuo2, Seiji Kawano4.   

Abstract

Infectious diseases caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli are prevalent because of nosocomial infection. In addition, colonization of ESBL-producing E. coli in the intestinal tract of community dwellers due to the contamination of meat or environmental water is assumed to be one of the sources, but the causes have not been clarified. To analyze these factors, we investigated the difference in clonal groups using a combination of phylogenetic groups and multilocus sequence typing of ESBL-producing E. coli, which were obtained from the feces of an inpatient group in our hospital and a community-dwelling group living in a Japanese city. The carriage rate of ESBL-producing E. coli in the inpatient group was 12.5% (32/257), similar to that of 8.5% (42/496) in the community dwellers (P = 0.082). Of the ESBL clonal groups detected from the community dwellers, 52% (22/42) were clonal groups, including D-ST1485, D-ST70, D-ST2847, B2-ST550, B2-ST3510, A-ST93, A-ST580, A-ST716 and B1-ST2787, that have not been detected from human pathogens, meat, companion animals and environmental water, whereas all clonal groups detected from the inpatients were those that had already been reported. The rate of fluoroquinolone-resistant ESBL clonal groups colonizing the intestinal tract of the inpatient group rose as the number of hospital days increased. These results indicated that different factors were related to colonization of ESBL-producing E. coli in the feces of the inpatient group and the community-dwelling group.
Copyright © 2015 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ESBL; Epidemiology; Escherichia coli; Molecular characterization

Mesh:

Substances:

Year:  2015        PMID: 26705747     DOI: 10.1016/j.jiac.2015.11.001

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  5 in total

1.  Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages.

Authors:  Amee R Manges; Hyun Min Geum; Alice Guo; Thaddeus J Edens; Chad D Fibke; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2019-06-12       Impact factor: 26.132

2.  Wastewater as a Probable Environmental Reservoir of Extended-Spectrum-β-Lactamase Genes: Detection of Chimeric β-Lactamases CTX-M-64 and CTX-M-123.

Authors:  Hayato Tanaka; Wataru Hayashi; Masaki Iimura; Yui Taniguchi; Eiji Soga; Nao Matsuo; Kumiko Kawamura; Yoshichika Arakawa; Yukiko Nagano; Noriyuki Nagano
Journal:  Appl Environ Microbiol       Date:  2019-10-30       Impact factor: 4.792

Review 3.  Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli between healthcare and community settings: a systematic review and meta-analysis.

Authors:  Yihienew M Bezabih; Alemayehu Bezabih; Michel Dion; Eric Batard; Samson Teka; Abiy Obole; Noah Dessalegn; Alelegn Enyew; Anna Roujeinikova; Endalkachew Alamneh; Corinne Mirkazemi; Gregory M Peterson; Woldesellassie M Bezabhe
Journal:  JAC Antimicrob Resist       Date:  2022-06-02

4.  Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.

Authors:  Yuko Komatsu; Kei Kasahara; Takashi Inoue; Sang-Tae Lee; Tetsuro Muratani; Hisakazu Yano; Tadaaki Kirita; Keiichi Mikasa
Journal:  PLoS One       Date:  2018-08-29       Impact factor: 3.240

5.  Extended-spectrum β-lactamase-producing Escherichia coli isolated from raw vegetables in South Korea.

Authors:  Jihyun Song; Sung-Suck Oh; Junghee Kim; Jinwook Shin
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.